Pharma Market & FDA Outlook
Upcoming PDUFA dates and drug approval forecasts, market size, company budgets, the heaviest workloads, and the CRO and software markets that serve them.
6 articles
- Upcoming FDA Drug Approvals: PDUFA Dates to Watch, Late 2026 to 2027 How PDUFA dates work, what 2026 approvals show, and the drug approval decisions to watch, each traced back to the sponsor's own disclosure.
- FDA Drug Approval Forecast 2027-2030: Will Biotech Startups Drive More Approvals? A transparent forecast of novel FDA drug approvals to 2030, built from FDA counts, the number of developers, pipeline size and venture funding.
- Pharmaceutical Market Size 2026: Global and US Spending, Growth, and Outlook to 2030 How big the pharmaceutical market is in 2026, globally and in the US, why list and net figures differ, and the outlook to 2030.
- Where Big Pharma's Money Goes: Budget Allocation from 2025 Financial Statements How five large pharma companies split their 2025 budgets across R&D, SG&A, capex, deals and shareholder returns, as a share of revenue.
- The Heaviest Workloads in Pharma: Where Time and Money Go in 2026 The heaviest pharma workloads ranked by cost, time and document volume: clinical development, submissions, pharmacovigilance and quality.
- Pharma Outsourcing and Software Market Size: CRO, Regulatory, Pharmacovigilance, and Quality Market sizes for CROs, eClinical, regulatory outsourcing, medical writing, pharmacovigilance and quality software, checked against revenue.
Subjects covered
- upcoming FDA drug approvals
- PDUFA dates
- FDA drug approval forecast
- novel drug approvals
- pharmaceutical market size
- pharma market outlook
- pharma R&D spending
- pharma budget allocation
- pharma workload burden
- CRO market size
- eClinical market
- regulatory affairs outsourcing market